Same role and same treatment for airway eosinophilia in asthma and COPD?

European Respiratory Journal

Volumn 29, Issue 5, 2007, Pages 831-833

  Maestrelli, Piero ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BRONCHODILATING AGENT; CORTICOSTEROID; INFLUENZA VACCINE; LONG ACTING DRUG; NITRIC OXIDE; OXYGEN; PNEUMOCOCCUS VACCINE; PREDNISOLONE; SALMETEROL;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DETERIORATION; DISEASE CONTROL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DYSPNEA; EDITORIAL; EOSINOPHIL COUNT; EOSINOPHILIA; EXERCISE; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HUMAN; INFLUENZA; INFLUENZA VACCINATION; NUTRITIONAL SUPPORT; OXYGEN THERAPY; PREDICTION; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY TRACT INFLAMMATION; SMOKING CESSATION; STREPTOCOCCUS INFECTION; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ASTHMA; EOSINOPHILIA; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM;

EID: 34248195418     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00022507     Document Type: Editorial

References (12)

1. Workshop report: Global Initiative for Asthma - updated 2006. www.ginasthma.com/GuidelinesResources.asp?11=2&12=0 Date last accessed: February 12, 2007.
2. Workshop report: Global Initiative for Chronic Obstructive Lung Disease - updated 2006. Available from www.who.int/respiratory/copd/ GOLD_WR_06.pdf Date last accessed: February 12, 2007.
3. Nannini L, Cates CJ, Lasserson TJ, Poole P. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2004; 3: CD003794.
4. Kardos P, Wencker M, Glaab T, Vogelmeier C. Impact of salmeterol/ fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 144-149.
5. Siva R, Green RH, Brightling CE, et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J 2007; 29: 906-913.
6. BTS guidelines for the management of COPD. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997; 52: Suppl. 5, s1-s28.
7. Leigh R, Pizzichini MM, Morris MM, Maltais F, Hargreave FE, Pizzichini E. Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment. Eur Respir J 2006; 27: 964-971.
8. Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002; 57: 875-879.
9. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360: 1715-1721.
10. Deykin A, Lazarus SC, Fahy JV, et al. Sputum eosinophil count predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol 2005; 115: 720-727.
11. Malinovschi A, Janson C, Holmkvist T, Norback D, Merilainen P, Hogman M. Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters. Eur Respir J 2006; 28: 339-345.
12. de Gouw HWFM, Hendriks J, Woltman AM, Twiss IM, Sterk PJ. Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma. Am J Respir Crit Care Med 1998; 158: 315-318.